🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Globus Medical, Inc.

GMED Healthcare
$85.9 $-0.04 (-0.05%)
Market Cap: $11.53 B
Gurus Holding
9
Popularity Rank
#726
% of Shares Held
1.09%
Net Activity (Q2 2026)
-$32.77 M

Guru Ownership Trend

Guru Analysis for Globus Medical, Inc. (GMED)

Globus Medical, Inc. (GMED), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 9 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $126.25 M.

Top institutional holders include Jeremy Grantham and Ray Dalio.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $32.77 M net outflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who opened a new position. Conversely, Cliff Asness reduced exposure by 95.7%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$31.79 M
Total Buy Value
New Buys 2
Additions 3
-$64.56 M
Total Sell Value
Reductions 2
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
3
Net Buyers
5

FAQs for Globus Medical, Inc. (GMED)

Major holders include Jeremy Grantham ($32.37 M), Ray Dalio ($27.81 M), Joel Greenblatt ($22.36 M). According to the latest reported data, 9 tracked investment managers collectively hold approximately 1.47 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $32.77 M, with 5 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited GMED. The total reported sell value was $64.56 M.

Yes, 2 managers opened new positions in GMED, and 3 increased their existing holdings. The total reported buy value was $31.79 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.07% Add 2.0% 409,705 $32.37 M Q2 2026
0.11% Add 6.5% 351,974 $27.81 M Q2 2026
0.05% Add 89.8% 283,058 $22.36 M Q2 2026
0.02% New Buy 196,918 $15.56 M Q2 2026
0.09% Reduce 0.0% 129,217 $10.21 M Q2 2026
0.76% New Buy 42,000 $3.32 M Q2 2026
0.00% Reduce -95.7% 36,534 $2.85 M Q2 2026
0.01% New Buy 14,369 $1.24 M Q1 2026
0.01% 6,008 $474,692 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form